Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer
- Eur J Med Chem. 2019 Apr 15:168:405-413. doi: 10.1016/j.ejmech.2019.02.047.
- 1. Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, 92093-0358, USA; Department of Chemistry, Faculty of Science, King Mongkut's University of Technology Thonburi, 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Bangkok, 10140, Thailand.
- 2. Department of Molecular and Cellular Biosciences, Rowan University, Glassboro, NJ, 08028, USA.
- 3. Department of Biology, Arcadia University, Glenside, PA, 19038, USA.
- 4. Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, 92093-0358, USA.
- 5. Department of Biology, Arcadia University, Glenside, PA, 19038, USA. Electronic address: [email protected].
- 6. Department of Molecular and Cellular Biosciences, Rowan University, Glassboro, NJ, 08028, USA. Electronic address: [email protected].
- 7. Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, CA, 92093-0358, USA. Electronic address: [email protected].
Inflammatory breast Cancer (IBC) is a highly metastatic, lethal form of breast Cancer that lacks targeted therapeutic strategies. Inspired by the promising cytotoxicity of gambogic acid and related caged Xanthones in spheroidsMARY-X, an in vitro preclinical IBC model, we constructed a library of synthetic analogs and performed structure-activity relationship studies. The studies revealed that functionalizing the A-ring of the caged xanthone framework can significantly affect potency. Specifically, introduction of hydroxyl or fluorine groups at discrete positions of the A-ring leads to enhanced cytotoxicity at submicromolar concentrations. These compounds induce complete dissolution of spheroidsMARY-X with subsequent Apoptosis of both the peripherally- and centrally-located cells, proliferative and quiescent-prone (e.g. hypoxic), respectively. These results highlight the structural flexibility and pharmacological potential of the caged xanthone motif for the design of IBC-targeting therapeutics.